Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation
US5783591A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Nov 17, 1994 |
| Grant date | Jul 21, 1998 |
| Priority date | — |
| Expiry date | Nov 17, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical preparations for the local treatment of inflammations are claimed herein, characterized in that they contain as the active ingredient one or two compounds of general Formula I ##STR1## wherein X is an oxygen atom or a methylene group, PA1 R.sub.1 and R.sub.2 represent a hydrogen atom or a hydrocarbon residue of maximally eight carbon atoms, optionally interrupted by an oxygen atom, PA1 R.sub.3 is a hydrogen atom or a hydrocarbon residue of maximally eight carbon atoms, optionally substituted by an oxo group, and PA1 R.sub.4 is a hydrogen atom or an alkyl group of maximally four carbon atoms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.